Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment

J Oral Maxillofac Surg. 2008 Jun;66(6):1320-1; author reply 1321-2. doi: 10.1016/j.joms.2008.01.054.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Administration, Oral
  • Biomarkers / blood
  • Bone Density Conservation Agents / administration & dosage
  • Bone Density Conservation Agents / adverse effects*
  • Collagen Type I / blood
  • Diphosphonates / administration & dosage
  • Diphosphonates / adverse effects*
  • Humans
  • Jaw Diseases / blood*
  • Jaw Diseases / chemically induced
  • Osteonecrosis / blood*
  • Osteonecrosis / chemically induced
  • Peptides / blood
  • Risk Factors

Substances

  • Biomarkers
  • Bone Density Conservation Agents
  • Collagen Type I
  • Diphosphonates
  • Peptides
  • collagen type I trimeric cross-linked peptide